A Clinical Efficacy Prediction Study of Acupuncture treatment for Migraine Based on Multimodal Neuroimaging Technology and Gene Polymorphism

Not Applicable

Recruiting

• Conditions: Migraine

• Registration Number: ITMCTR2100004847
• Lead Sponsor: Chengdu University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1.Aged from 18 to 65 years;
2.Migraine without aura patients: meetting the ICHD-3 2018 edition diagnostic criteria for migraine (without aura) published by the International Headache Society;
3.Tension-type headache patients: meetting the ICHD-3 2018 edition diagnostic criteria for primary tension-type headache published by the International Headache Society;
4.Right handedness;
5.With a history of migraine or tension-type headache for over 6 months;
6.Migraine or tension-type headache attacks more than once a month in the past 3 months;
7.Did not receive no acupuncture treatment in the past 3 months;
8.Did not take any preventive, long-acting analgesics, psychotropic drugs (such as Prozac and estazolam eurodin) or vasoactive drugs for migraine or tension-type headache in the past 3 months;
9.The informed consent is signed by the patient himself or his immediate family member.
Note: Only those who meet each of the above 9 criteria can be included in the study.

Exclusion Criteria

1.Suffering from other pain conditions;
2.Suffering from mental disorders (such as primary anxiety, primary depression, schizophrenia, etc.);
3.Suffering from cognitive and consciousness disorder who cannot comply with the experiment procedure;
4.Suffering from cancer, circulation, phumalnory, urinary, hematopoietic and other systems serious primary diseases;
5.Being pregnant or lactating;
6.Patients who have a history of alcohol or drug abuse or drug addiction;
7.Having acupuncture contradictions;
8.Having MRI contraindications (such as there are metal implants in the body, or suffer from claustrophobia syndrome, etc.).
Note: Those who meet any of the above 8 criteria should be excluded in the study.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber of headache days;Number of headache attacks;

Secondary Outcome Measures

Name	Time	Method
The use of non-steroidal drug;Emotion-related scale;Average VAS scores for headaches;Effective rate;